Skip to content

Clinical trials

Terminated Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Status: Terminated Country / region: Japan Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20082
20092
20103
20111
20122
20131
20142
20161
20173
20182
20193
20207
20212
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie9
Pfizer4
AstraZeneca3
Novartis Pharmaceuticals3
Amgen2
Blueprint Medicines Corporation2
Celgene2
Egetis Therapeutics2
GlaxoSmithKline2
Abbott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms39
Carcinoma, Non-Small-Cell Lung9
Neoplasm Metastasis7
Adenocarcinoma5
Neoplasms by Site5
Carcinoma4
Colorectal Neoplasms4
Lung Neoplasms4
Multiple Myeloma4
Neoplasms by Histologic Type4

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.